[The influence of genetic factors on the effectiveness of eradication therapy of Helicobacter pylori infection in children].

Efficacy of sequential eradication therapy for H. pylori was studied in 176 adolescents (mean age 14.3 years) with different PPI metabolism types.

[Rifaximin in combined treatment of the Helicobacter pylori infection in childhood].

Aim: To provide a pilot study of empiric rifaximin, bismuth subcitrate, furazolidone/nifuratel triple therapy for H. pylori gastritis in childhood.

Materials And Methods: Forty one pediatric outpatients (27 females, mean age 14.

[Immune polymorphism analysis of HLA class II antigens in ulcer diseases associated with Helicobacter pylori in children].

Unlabelled: Previous investigations have linked specific HLA class II alleles DRB1 and DQB1 to H. pylori infection (Y. Huang et al.

[Study of gene polymorphism responsible for metabolism of proton pump inhibitors in children with H. pylori infection: is there a correlation with efficacy of eradication treatment?].

Unlabelled: THE AIM of this study was to determine the effects of CYP2C19 polymorphism on H. pylori eradication in pediatric population in the Republic of Bashkortostan.

Methods: Fifty-nine children were entered into the study (age range: 12 to 17; 22 female).

[Rifaksimin in complex treatment of Helicobacter pylori infection in children (a pilot study)].

Aim: To provide a pilot study of empiric rifaximin, bismuth subcitrate, furazolidone/nifuratel triple therapy for H. pylori gastritis in childhood.

Materials And Methods: Forty one pediatric outpatients (27 females, mean age 14.